Long Covid affects millions of people worldwide and claims many lives each day. To prevent it, updated Covid-19 vaccines are essential, as they can help reduce the risk of contracting the virus and its variants.
The new vaccines, developed by Moderna and Pfizer-BioNTech, target the omicron subvariants and can be effective in reducing severe disease and hospitalization. Novavax vaccine is also protein-based, which further enhances its effectiveness. Despite the monumental accomplishments of developing and rolling out the groundbreaking vaccines, vaccine rates have lagged.